Evidence map›Paper›PMID 41794439›Full record

ArticleTransplantation and cellular therapy2026

Redefining Curative Intent in Severe Aplastic Anemia-When Access, Durability, and Biology Finally Align.

Akshay Sharma

Abstract read
In one paragraph

Article in Transplantation and cellular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Akshay SharmaDepartment of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN.. Electronic address: akshay.sharma@stjude.org.

Funding

Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell diseaseU01HL163983 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Akshay Sharma, Shengdar Tsai · 2023 to 2026
$4.9M
NHLBI NIH HHS U01 HL163983
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Baltimore regimenhaploidentical transplantationpost-transplant cyclophosphamidesevere aplastic anemia

Identifiers

PMID41794439
PMCPMC13641833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.